Syntec Optics (Nasdaq: OPTX) Enabling Optics for Near Vision Correction

ROCHESTER, NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX), a leading provider of technology products to defense, biomedical, communications, and consumer industry leaders, today announced it is enabling optics for the clinical development of innovative, non-incisional optics-based refractive error correction to recover near vision. This common age-related vision condition, affecting an estimated 128 million people in the U.S. alone, presents a significant and growing market opportunity for effective treatment solutions.